Bluejay Diagnostics, Inc. BJDX 深 沪
已收盘 07-02 16:00:00 美东时间
1.14
-0.060
-5.00%
华盛通- 最 高1.21
- 今 开1.18
- 成交量 32.19万股
- 最 低 1.03
- 昨 收 1.20
- 总市值 117.96万
- 52周最高 16.68
- 市盈率 静 --
- 换手率 31.11%
- 52周最低 1.03
- 委 比 32.05%
- 总股本 103.47万
- 历史最高 200000.00
- 量 比 0.36
- 振 幅 15.00%
- 历史最低 1.03
- 每 手 1
- 风险率 2.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Regentis Biomaterials (AMEX:RGNT) stock rose 128.9% to $2.93 during Tu...
06-09 20:05
What's Going On With Bluejay Diagnostics Shares On Wednesday?
Bluejay Diagnostics shares fall after announcing a private placement that could generate up to $23.6 million in gross proceeds.
06-03 23:48
Why Is Bluejay Diagnostics Stock Soaring Tuesday?
Bluejay Diagnostics partners with Argonaut to scale U.S. manufacturing and distribution for its Symphony critical care platform. Stock jumps.
06-02 20:20
Market-Moving News for June 2nd
HPE: 30% | Hewlett Packard Enterprise shares are trading higher after the company reported better-than-expected Q2 financial results BJDX: 200% | Bluejay Diagnostics Announces Strategic Partnership With
06-02 19:24
Bluejay Diagnostics Announces Strategic Partnership With Argonaut Manufacturing Services To Support Advancement Of Bluejay's Symphony Platform
Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ:BJDX), a medical diagnostics company focused on near-patient testing for critical care, today announced a strategic partnership with Argonaut Manufacturing
06-02 18:31
Why Etsy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Shares of Etsy Inc (NYSE:ETSY) rose sharply in pre-market trading after the com...
02-19 17:25
Bluejay Diagnostics Announces 1-For-4 Reverse Stock Split, Effective Jan. 29
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today
01-27 21:04
Bluejay Diagnostics Completes Commercial-Scale Production Of Polyclonal And Monoclonal Antibodies Targeting Interleukin-6, Biomarker Relevant To Inflammatory And Critical-Care Applications
The Company stated that both polyclonal and monoclonal antibodies met internal performance criteria, including reactivity, for use in Symphony™ cartridge manufacturing intended for clinical and potential future
2025-12-29 20:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 208.1% to $27.33...
2025-11-13 20:06
